Drug Type Small molecule drug |
Synonyms Dexaneurosone |
Target |
Action agonists, stimulants |
Mechanism GR agonists(Glucocorticoid receptor agonists), Neurogenesis stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| COVID-19 | Clinical | United States | 08 Aug 2022 |





